- Home
- RLAY vs PRG Comparison
RLAY vs PRG Comparison
Compare RLAY & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | PRG |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | PRG |
|---|---|---|
| Price | $8.29 | $30.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $16.00 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 2.2M | 633.1K |
| Earning Date | 11-06-2025 | 02-18-2026 |
| Dividend Yield | N/A | ★ 1.71% |
| EPS Growth | N/A | ★ 10.59 |
| EPS | N/A | ★ 3.96 |
| Revenue | $8,355,000.00 | ★ $2,507,179,000.00 |
| Revenue This Year | $20.47 | $1.24 |
| Revenue Next Year | N/A | $7.02 |
| P/E Ratio | ★ N/A | $7.70 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $1.78 | $23.50 |
| 52 Week High | $9.04 | $44.43 |
Technical Indicators
Market Signals| Indicator | RLAY | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 57.67 | 55.28 |
| Support Level | $8.13 | $29.76 |
| Resistance Level | $8.76 | $30.58 |
| Average True Range (ATR) | 0.48 | 0.80 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 54.63 | 51.45 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.